TY  - JOUR
T1  - The Age of Digital Pharmaceuticals: Exploring 3D Printing – Present Realities and Future Outlook
A1  - Philippe Lefevre
A1  - Sophie Martin
A1  - Louis Bernard
JF  - Annals of Pharmacy Practice and Pharmacotherapy
JO  - Ann Pharm Pract Pharmacother
SN  - 3062-4436
Y1  - 2025
VL  - 5
IS  - 1
DO  - 10.51847/VLAfgBLH2U
SP  - 1
EP  - 12
N2  - 3D printing represents a cutting-edge approach for fabricating three-dimensional structures through the layer-by-layer deposition of materials guided by computer software. Its integration into the pharmaceutical field is driven by its transformative capacity to produce customized dosage forms tailored to individual patient requirements, as it allows for the fabrication of products in diverse sizes and geometries. A key benefit of personalized 3D-printed tablets lies in their ability to incorporate multiple active ingredients within a single dosage unit, thereby minimizing the number of daily medications, reducing dosing frequency, and enhancing treatment adherence. Moreover, this technology enables the manufacturing of limited or patient-specific batches, offering flexibility in drug production. However, several technical obstacles must be addressed before 3D printing can achieve broad implementation in pharmacy. Currently, five principal 3D printing methods are utilized in pharmaceutical research and development: powder bed printing, selective laser sintering, stereolithography, extrusion-based printing, and electrohydrodynamic 3D printing. This review explores the progress, research emphasis, and future potential of each of these technologies.
UR  - https://galaxypub.co/article/the-age-of-digital-pharmaceuticals-exploring-3d-printing-present-realities-and-future-outlook-zslccuso5ffoa7l
ER  -